These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 9430646)
1. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. Roth J; Dobbelstein M; Freedman DA; Shenk T; Levine AJ EMBO J; 1998 Jan; 17(2):554-64. PubMed ID: 9430646 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Henderson BR; Eleftheriou A Exp Cell Res; 2000 Apr; 256(1):213-24. PubMed ID: 10739668 [TBL] [Abstract][Full Text] [Related]
3. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Tao W; Levine AJ Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3077-80. PubMed ID: 10077639 [TBL] [Abstract][Full Text] [Related]
4. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage. Joseph TW; Zaika A; Moll UM FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168 [TBL] [Abstract][Full Text] [Related]
5. MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm. Phelps M; Phillips A; Darley M; Blaydes JP J Biol Chem; 2005 Apr; 280(17):16651-8. PubMed ID: 15723837 [TBL] [Abstract][Full Text] [Related]
6. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. Xirodimas DP; Stephen CW; Lane DP Exp Cell Res; 2001 Oct; 270(1):66-77. PubMed ID: 11597128 [TBL] [Abstract][Full Text] [Related]
7. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Boyd SD; Tsai KY; Jacks T Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695 [TBL] [Abstract][Full Text] [Related]
8. Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation. Migliorini D; Danovi D; Colombo E; Carbone R; Pelicci PG; Marine JC J Biol Chem; 2002 Mar; 277(9):7318-23. PubMed ID: 11744695 [TBL] [Abstract][Full Text] [Related]
9. The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Krätzer F; Rosorius O; Heger P; Hirschmann N; Dobner T; Hauber J; Stauber RH Oncogene; 2000 Feb; 19(7):850-7. PubMed ID: 10702793 [TBL] [Abstract][Full Text] [Related]
10. Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage. Shirangi TR; Zaika A; Moll UM FASEB J; 2002 Mar; 16(3):420-2. PubMed ID: 11790725 [TBL] [Abstract][Full Text] [Related]
11. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Laín S; Midgley C; Sparks A; Lane EB; Lane DP Exp Cell Res; 1999 May; 248(2):457-72. PubMed ID: 10222137 [TBL] [Abstract][Full Text] [Related]
12. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427 [TBL] [Abstract][Full Text] [Related]
13. Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects. Ionov Y; Le X; Tunquist BJ; Sweetenham J; Sachs T; Ryder J; Johnson T; Lilly MB; Kraft AS Anticancer Res; 2003; 23(1A):167-78. PubMed ID: 12680209 [TBL] [Abstract][Full Text] [Related]
14. A cis-acting peptide signal in human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins. Kubota S; Pomerantz RJ Oncogene; 1998 Apr; 16(14):1851-61. PubMed ID: 9583682 [TBL] [Abstract][Full Text] [Related]
15. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination. O'Keefe K; Li H; Zhang Y Mol Cell Biol; 2003 Sep; 23(18):6396-405. PubMed ID: 12944468 [TBL] [Abstract][Full Text] [Related]
17. Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals. Meyer BE; Meinkoth JL; Malim MH J Virol; 1996 Apr; 70(4):2350-9. PubMed ID: 8642662 [TBL] [Abstract][Full Text] [Related]
18. MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA. Phillips A; Blaydes JP Oncogene; 2008 Mar; 27(11):1645-9. PubMed ID: 17828301 [TBL] [Abstract][Full Text] [Related]
19. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Tao W; Levine AJ Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6937-41. PubMed ID: 10359817 [TBL] [Abstract][Full Text] [Related]
20. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Zhang Y; Xiong Y Science; 2001 Jun; 292(5523):1910-5. PubMed ID: 11397945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]